期刊文献+

结外NK/T细胞淋巴瘤分子机制研究进展 被引量:2

Progress of molecular pathogenesis of extranodal natural killer/T-cell lymphoma
原文传递
导出
摘要 结外NK/T细胞淋巴瘤(ENKTCL)是一种高度侵袭性的非霍奇金淋巴瘤(NHL),死亡率高。ENKTCL主要发生在亚洲、拉丁美洲等地区,中国、日本、韩国是该肿瘤的高发国家。EB病毒(EBV)感染与ENKTCL的发病密切相关,但导致其发病的具体分子机制尚不清楚。我国是ENKTCL的高发国家,有着丰富的病例资源,我国学者在探索ENKTCL的发病机制、治疗方法等方面做出了重要贡献,文章就近年来ENKTCL分子机制研究进展进行综述。 Extranodal nature killer/T cell lymphoma (ENKTCL) is a highly aggressive non-Hodgkin lymphoma (NHL) with a high mortality. ENKTCL is epidemic in Asia and Latin America, especially in China, Japan and South Korea. EBV has been proved to be associated closely with ENKTCL; however, specific molecular mechanism which can explain how the neoplasm develops is still unclear. Chinese population seems to be more susceptible to this lymphoma and Chinese scientists have made great contributions to thepathogenesis and the treatments of ENKTCL. This review mainly introduces the recent progress of molecular pathogenesis of ENKTCL.
作者 尹文娟 吴梅娟 Yin Wenjuan;Wu Meijuan(Department of Pathology,Zhejiang Cancer Hospital,Hangzhou 310022,China;Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province,Hangzhou 310022,China)
出处 《白血病.淋巴瘤》 CAS 2018年第9期570-573,共4页 Journal of Leukemia & Lymphoma
基金 浙江省医药卫生科技项目面上项目(2018245519)
关键词 淋巴瘤 结外NK-T细胞 分子机制 Lymphoma extranodal NK-T-cells Molecular pathogenesis
  • 相关文献

参考文献4

二级参考文献40

  • 1肖畅,苏祖兰,吴秋良,郜红艺,方建晨,夏忠军,管忠震.根据WHO新分类对493例非霍奇金淋巴瘤的临床病理分析[J].中华病理学杂志,2005,34(1):22-27. 被引量:54
  • 2曹素梅,郭翔,李宁炜,向燕群,洪明晃,闵华庆.1 142例住院广东籍鼻咽癌患者的临床资料分析[J].癌症,2006,25(2):204-208. 被引量:21
  • 3Wang J,Young L,Win W,et al.Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi,China:a review of 447 cases using a tissue microarray technique.Appl Immunohistochem Mol Morphol,2005,13(4):323-332.
  • 4Aoki R,Karube K,Suglta Y,et al.Distribution of malignant lymphoma in Japan:analysis of 2260 cases,2001-2006.Pathol Int,2008,58(3):174-182.
  • 5Lee MY,Tan TD,Feng AC,et al.Clinicopathological analysis of 598 malignant lymphomas in Taiwan:seven-year expenence in a single institution.Am J Hematol,2006,81(8):568-575.
  • 6Au WY,Ma SY,Chim CS,et al.Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphornas diagnosed according to the World Health Organization classification scheme:a single center experience of 10 years.Ann Oncol,2005,16(2):206-214.
  • 7Kobayashi R,Yamato K,Tanaka F,et al.Retrospective analysis of non-anaplastic peripheral T-cell lymphoma in pediatric patients in Japan.Pediatr Blood Cancer,2010,54(2):212-215.
  • 8Windsor R,Stiller C,Webb D.Peripheral T-cell lymphoma in childhood:population-based experience in the United Kingdom over 20 years.Pediatr Blood Cancer,2008,50(4):784-787.
  • 9Savage KJ,Chhanabhai M,Gascoyne RD,et al.Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification.Ann Oncel,2004,15(10):1467-1475.
  • 10Vose J,Armitage J,Weisenburger D,et al.International peripheral T-cell and natural killer/T-cell lymphoma study:pathology findings and chinical outcomes.J Clin Oncol,2008,26(25):4124-4130.

共引文献29

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部